Product Information
POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1153 per EA under NDC 16571084250. Its NADAC has been published 47 times since Aug 6, 2025.
Strength
600 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571084250
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217412On Market Since
2/13/2025
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 47 times since Aug 6, 2025, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1153 per EA |
|---|---|
| All-time high | $0.1413 (Sep 10, 2025) |
| All-time low | $0.1153 (Jun 17, 2026) |
| 52-week high | $0.1413 |
| 52-week low | $0.1153 |
| Median price | $0.1369 |
| Average price | $0.1328 |
| Largest weekly change | -8.3% (Feb 18, 2026) |
| Weeks tracked | 47 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1153 per EA (NDC 16571084250), effective Jun 24, 2026.
How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 17.4%. It has been tracked across 47 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?
Since Aug 6, 2025, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1153 (Jun 17, 2026) to a high of $0.1413 (Sep 10, 2025), with a median of $0.1369 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ CAPSULE, is $0.1025 per EA — about 11% below POTASSIUM CL ER 8 MEQ TABLET.
Who manufactures POTASSIUM CL ER 8 MEQ TABLET?
POTASSIUM CL ER 8 MEQ TABLET (NDC 16571084250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification